Inhibitors of kidney-type glutaminase, GLS-1
US10526322B2 · kind B2 · utility
2Cited by
3References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 5, 2015 |
| Grant date | Jan 7, 2020 |
| Priority date | — |
| Expiry date | Dec 5, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/98
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates generally to glutaminase inhibitors of Formula I, Formula II, or Formula III, as well as pharmaceutical compounds containing them and methods of their use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.